Literature DB >> 11182366

Different docetaxel-induced apoptotic pathways are present in prostate cancer cell lines LNCaP and PC-3.

H J Muenchen1, P J Poncza, K J Pienta.   

Abstract

OBJECTIVES: To investigate the molecular machinery of docetaxel (Taxotere)-initiated death signaling on prostate cancer cell lines LNCaP and PC-3. Taxotere is a member of the taxane family of chemotherapeutic agents. It has been shown to disrupt microtubule dynamics causing mitotic arrest, which leads to cell death. Taxotere has demonstrated induction of cell death in LNCaP and PC-3 cells. However, the pathways by which apoptosis occurs differ in each cell line.
METHODS: The prostate cancer cell lines, LNCaP and PC-3, were treated with 40 nM Taxotere for various lengths of time (0.5 to 24 hours). Western blot analysis was used for protein analysis.
RESULTS: LNCaP cells demonstrated caspase-3 and caspase-7 cleavage, and PC-3 cells demonstrated only caspase-8 and BH3-interacting domain death agonist cleavage. Only LNCaP cells were observed to express clusterin expression; PC-3 cells expressed a novel apoptosis inhibitor, survivin.
CONCLUSIONS: In this study, we demonstrated two distinctly different Taxotere-induced apoptotic pathways in LNCaP and PC-3 cells that may be of clinical importance when treating prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11182366     DOI: 10.1016/s0090-4295(00)00935-3

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  Regulation of microtubule, apoptosis, and cell cycle-related genes by taxotere in prostate cancer cells analyzed by microarray.

Authors:  Yiwei Li; Xingli Li; Maha Hussain; Fazlul H Sarkar
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

2.  Oxidized low-density lipoprotein is associated with advanced-stage prostate cancer.

Authors:  Fangning Wan; Xiaojian Qin; Guiming Zhang; Xiaolin Lu; Yao Zhu; Hailiang Zhang; Bo Dai; Guohai Shi; Dingwei Ye
Journal:  Tumour Biol       Date:  2015-01-08

3.  Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G1 Arrest/S Phase Delay and Inhibition of Apoptosis During Chemotherapy in Bone Marrow.

Authors:  Eunsohl Lee; Ann M Decker; Frank C Cackowski; Lulia A Kana; Kenji Yumoto; Younghun Jung; Jingcheng Wang; Laura Buttitta; Todd M Morgan; Russell S Taichman
Journal:  J Cell Biochem       Date:  2016-09-26       Impact factor: 4.429

Review 4.  Docetaxel in hormone-refractory metastatic prostate cancer.

Authors:  Kate McKeage; Susan J Keam
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  The Combination of Omega-3 Stearidonic Acid and Docetaxel Enhances Cell Death over Docetaxel Alone in Human Prostate Cancer Cells.

Authors:  Mahmoud Mansour; Sabrina van Ginkel; John C Dennis; Brandon Mason; Isra Elhussin; Kodye Abbott; Satyanarayana R Pondugula; Temesgen Samuel; Edward Morrison
Journal:  J Cancer       Date:  2018-11-11       Impact factor: 4.207

6.  Cellular uptake and cytotoxicity studies of pH-responsive polymeric nanoparticles fabricated by dispersion polymerization.

Authors:  Reema Puri; Simeon Adesina; Emmanuel Akala
Journal:  J Nanosci Nanomed       Date:  2018-04-12

7.  Aqueous Extract of Solanum nigrum Leaf Activates Autophagic Cell Death and Enhances Docetaxel-Induced Cytotoxicity in Human Endometrial Carcinoma Cells.

Authors:  Cheng-Jeng Tai; Chien-Kai Wang; Yu-Jia Chang; Chi-Shian Lin; Chen-Jei Tai
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-08       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.